SIGACHI

Sigachi Industries Limited

Sigachi Industries Limited (SIGACHI) financial statements and selected valuation metrics through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

sigachi.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹27.52
Market cap
1,052 Cr
Stock P/E
41.5
P/B
2.02
Dividend yield
0.4%
ROE (FY26)
-15.5%
ROCE (FY26)
-11.1%
Operating margin (FY26)
7.6%
Debt / equity (FY26)
0.26
OCF / EBITDA (FY26)
8.0%
OCF / EBITDA (3Y)
19.2%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Sigachi makes microcrystalline cellulose (MCC), an excipient that drug and food-supplement makers use in their formulations, and sells it mostly to export customers through distributors.

Company snapshot

91stBy market cap

Ranked among 119 companies in Pharmaceuticals.

What we see

Positives
  • ✓Debt-to-equity of 0.26x — the company is largely funded by its own money, not borrowed funds.
Concerns
  • ✗Net margin is negative — the company is spending more than it earns right now.
2 more signals from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales99 Cr111 Cr104 Cr96 Cr125 Cr139 Cr128 Cr128 Cr110 Cr117 Cr122 Cr121 Cr
Operating expenses (approx.)78 Cr88 Cr88 Cr75 Cr108 Cr106 Cr100 Cr104 Cr103 Cr111 Cr105 Cr105 Cr
EBITDA21 Cr23 Cr16 Cr21 Cr17 Cr33 Cr29 Cr24 Cr8 Cr6 Cr16 Cr17 Cr
OPM %21.6%20.4%15.7%22.0%13.8%23.8%22.3%18.8%6.8%4.9%13.5%13.6%
Other income1 Cr2 Cr7 Cr2 Cr15 Cr2 Cr2 Cr4 Cr2 Cr0.47 Cr1 Cr1 Cr
Interest2 Cr2 Cr3 Cr3 Cr2 Cr4 Cr3 Cr3 Cr3 Cr3 Cr4 Cr3 Cr
Depreciation3 Cr3 Cr3 Cr3 Cr3 Cr5 Cr5 Cr5 Cr4 Cr4 Cr5 Cr4 Cr
Profit before tax18 Cr20 Cr17 Cr16 Cr27 Cr27 Cr23 Cr-101 Cr7 Cr-2 Cr8 Cr10 Cr
Tax %17.0%18.0%11.9%22.2%20.8%23.2%28.7%0.0%-41.6%99.1%0.8%19.3%
Net profit15 Cr16 Cr15 Cr13 Cr21 Cr21 Cr16 Cr-101 Cr11 Cr-0.02 Cr8 Cr8 Cr
EPS (₹)₹4.93₹0.51₹0.48₹0.40₹0.66₹0.65₹0.36₹-2.63₹0.28₹0.01₹0.20₹0.18

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales129 Cr139 Cr193 Cr250 Cr302 Cr399 Cr488 Cr478 CrSign in free for the trailing twelve months
Operating expenses (approx.)103 Cr114 Cr154 Cr197 Cr243 Cr322 Cr388 Cr424 CrSign in free for the trailing twelve months
EBITDA26 Cr25 Cr39 Cr53 Cr59 Cr77 Cr100 Cr54 CrSign in free for the trailing twelve months
OPM %20.1%17.8%20.1%21.2%19.4%19.2%20.5%11.2%Sign in free for the trailing twelve months
Other income4 Cr5 Cr3 Cr3 Cr7 Cr12 Cr21 Cr8 CrSign in free for the trailing twelve months
Interest3 Cr2 Cr1 Cr1 Cr4 Cr8 Cr12 Cr14 CrSign in free for the trailing twelve months
Depreciation2 Cr2 Cr2 Cr3 Cr7 Cr11 Cr16 Cr18 CrSign in free for the trailing twelve months
Profit before tax25 Cr25 Cr38 Cr52 Cr54 Cr70 Cr92 Cr-88 CrSign in free for the trailing twelve months
Tax %23.1%19.8%21.4%22.4%20.1%17.9%23.7%5.6%Sign in free for the trailing twelve months
Net profit19 Cr20 Cr30 Cr40 Cr44 Cr57 Cr70 Cr-83 CrSign in free for the trailing twelve months
EPS (₹)₹8.25₹8.81₹13.13₹15.44₹14.16₹1.81₹2.06₹-2.14Sign in free for the trailing twelve months
Dividend payout %———5.8%7.1%5.4%4.7%—Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital3 Cr8 Cr8 Cr31 Cr31 Cr33 Cr38 Cr38 Cr
Reserves42 Cr57 Cr87 Cr197 Cr238 Cr397 Cr563 Cr484 Cr
Borrowings23 Cr29 Cr20 Cr34 Cr40 Cr143 Cr142 Cr136 Cr
Other liabilities23 Cr16 Cr19 Cr25 Cr65 Cr110 Cr91 Cr177 Cr
Total liabilities91 Cr109 Cr133 Cr287 Cr374 Cr694 Cr846 Cr841 Cr
Fixed assets (net)28 Cr31 Cr38 Cr53 Cr122 Cr171 Cr288 Cr240 Cr
CWIP2 Cr3 Cr4 Cr10 Cr35 Cr97 Cr9 Cr31 Cr
Investments——0.15 Cr0.15 Cr0.15 Cr0.29 Cr0.15 Cr0.15 Cr
Inventories23 Cr28 Cr21 Cr30 Cr47 Cr71 Cr94 Cr74 Cr
Trade receivables25 Cr28 Cr36 Cr60 Cr80 Cr150 Cr184 Cr224 Cr
Cash & bank1 Cr9 Cr16 Cr29 Cr14 Cr17 Cr17 Cr21 Cr
Other assets13 Cr10 Cr19 Cr105 Cr77 Cr188 Cr255 Cr252 Cr
Total assets91 Cr109 Cr133 Cr287 Cr374 Cr694 Cr846 Cr841 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity14 Cr12 Cr30 Cr6 Cr29 Cr13 Cr27 Cr4 Cr
Cash from investing-6 Cr-7 Cr-11 Cr-63 Cr-92 Cr-161 Cr-93 Cr-53 Cr
Cash from financing-9 Cr3 Cr-11 Cr108 Cr26 Cr172 Cr81 Cr2 Cr
Net cash flow-0.43 Cr8 Cr7 Cr51 Cr-37 Cr24 Cr15 Cr-46 Cr
Free cash flow (OCF − Capex)9 Cr6 Cr20 Cr-18 Cr-72 Cr-72 Cr-16 Cr-37 Cr

Ratios

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %41.4%29.6%34.7%20.1%19.0%13.3%13.9%-11.1%
ROE %42.4%31.5%32.1%17.6%16.2%13.0%11.3%-15.5%
Debtor days7072688797137137171
Inventory days1171387990120161146134
Days payable463630315410955107
Cash conversion cycle141174117146163189228198
OCF / EBITDA %55.7%49.0%76.2%11.0%49.4%16.8%26.9%8.0%
OCF / EBITDA % (3 years)——62.7%40.8%42.8%25.3%29.2%19.2%
Debt / equity0.520.450.210.150.150.330.240.26
Current ratio1.411.842.713.502.381.672.131.44
Net debt / EBITDA0.850.820.110.100.461.641.252.13